Skip to main content

Synovium-Derived Mesenchymal Stem/Stromal Cells and their Promise for Cartilage Regeneration

  • Chapter
  • First Online:
Cell Biology and Translational Medicine, Volume 6

Part of the book series: Advances in Experimental Medicine and Biology ((CBTMED,volume 1212))

Abstract

Adult tissues are reservoirs of rare populations of cells known as mesenchymal stem/stromal cells (MSCs) that have tissue-regenerating features retained from embryonic development. As well as building up the musculoskeletal system in early life, MSCs also replenish and repair tissues in adult life, such as bone, cartilage, muscle, and adipose tissue. Cells that show regenerative features at least in vitro have been identified from several connective tissues. Bone marrow and adipose tissue are the most well recognized sources of MSCs that are already used widely in clinical practice. Regenerative medicine aims to exploit MSCs and their tissue regeneration even though the underlying mechanisms for their beneficial effects are largely unknown. Despite many studies that have used various tissue-derived MSCs, the most effective tissue source for orthopedic procedures still remains to be identified. Another question that needs to be addressed is how to evaluate autologous MSCs (i.e., patient derived). Previous studies have suggested the features of bone-marrow-derived MSCs can differ widely between individuals, and can be changed in particular in patients suffering from some forms of degenerative disorder, such as osteoarthritis. The synovium is a thin membrane that protects the synovial joints, and it is a rich source of MSCs that show great potential for regenerative medicine. Here, we review synovium-derived MSCs from reports on basic and clinical studies. We discuss their potential to treat cartilage defects caused by either degeneration or trauma, and what needs to be done in further research toward their better exploitation for joint regeneration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

Download references

Acknowledgments

Janja Zupan was funded by UK Arthritis Research (2016–2018) and is currently part of the P3-0298 Research Programme ‘Genes, hormones and personality changes in metabolic disorders’, funded by the Slovenian Research Agency, and ARTE Project EU INTERREG Italia-Slovenija 2014–2020. The authors would like to thank Chris Berrie for scientific English editing of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Klemen Stražar .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Zupan, J., Drobnič, M., Stražar, K. (2019). Synovium-Derived Mesenchymal Stem/Stromal Cells and their Promise for Cartilage Regeneration. In: Turksen, K. (eds) Cell Biology and Translational Medicine, Volume 6. Advances in Experimental Medicine and Biology(), vol 1212. Springer, Cham. https://doi.org/10.1007/5584_2019_381

Download citation

Publish with us

Policies and ethics